Շվեյցարիա - ֆրանսերեն - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer pfe switzerland gmbh - tolterodinum - retard-kapseln - tolterodini-l-tartras 2 mg corresp. tolterodinum 1.37 mg, color.: e 132, excipiens pro capsula. - behandlung der hyperaktiven blase - synthetika human

Շվեյցարիա - ֆրանսերեն - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer pfe switzerland gmbh - tolterodinum - retard-kapseln - tolterodini-l-tartras 4 mg corresp. tolterodinum 2.74 mg, color.: e 132, excipiens pro capsula. - behandlung der hyperaktiven blase - synthetika human

Կանադա - ֆրանսերեն - Health Canada

bausch health, canada inc. - chlorhydrate de metformine - comprimé - 850mg - chlorhydrate de metformine 850mg - biguanides

Կանադա - ֆրանսերեն - Health Canada

jamp pharma corporation - méthotrexate (méthotrexate sodique) - solution - 25mg - méthotrexate (méthotrexate sodique) 25mg - antineoplastic agents

Շվեյցարիա - ֆրանսերեն - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - tolterodinum - depocaps - tolterodini l-tartras 2 mg corresp. tolterodinum 1,37 mg, color.: e 132, excipiens pro de la capsule. - traitement de la vessie hyperactive - synthetika

Շվեյցարիա - ֆրանսերեն - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - tolterodinum - depocaps - tolterodini l-tartras 4 mg corresp. tolterodinum de 2,74 mg, color.: e 132, excipiens pro de la capsule. - traitement de la vessie hyperactive - synthetika

Կանադա - ֆրանսերեն - Health Canada

bausch health, canada inc. - chlorhydrate de metformine - comprimé - 500mg - chlorhydrate de metformine 500mg - biguanides

Շվեյցարիա - ֆրանսերեն - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - desfesoterodinum - depotabs - desfesoterodini succinas 3,5 mg corresp. desfesoterodinum 2,6 mg, color.: e 132, excipiens pro compresso obducto. - traitement de la vessie hyperactive - synthetika

Շվեյցարիա - ֆրանսերեն - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - desfesoterodinum - depotabs - desfesoterodini succinas 7 mg corresp. desfesoterodinum 5.2 mg, color.: e 132, excipiens pro compresso obducto. - traitement de la vessie hyperactive - synthetika

Եվրոպական Միություն - ֆրանսերեն - EMA (European Medicines Agency)

bayer ag - riociguat - hypertension pulmonaire - antihypertenseurs pour l'hypertension artérielle pulmonaire - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. l'efficacité a été démontrée dans une htap de la population, y compris les étiologies des idiopathique ou héréditaire de l'htap ou hap associée à une maladie du tissu conjonctif. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.